同和药业：10月24日召开董事会会议

Group 1 - The core point of the article is that Tonghua Pharmaceutical (SZ 300636) held its fourth board meeting on October 24, 2025, to review proposals including amendments to the company's articles of association [1] - For the first half of 2025, Tonghua Pharmaceutical's revenue composition shows that pharmaceutical manufacturing accounted for 99.51%, while other businesses contributed 0.49% [2] - As of the report date, Tonghua Pharmaceutical has a market capitalization of 3.7 billion yuan [3]